Tag: liver

HistoSonics announces first kidney tumour treatment using histotripsy

HistoSonics has announced the first kidney patient has been treated using its histotripsy platform. The procedure was performed at the Leeds Teaching Hospitals NHS...

Delcath Systems announces US FDA acceptance of Hepzato Kit new drug...

Delcath Systems has announced in a company press release that the US Food and Drug Administration (FDA) has accepted its (Delcath's) new drug application...
hepzato

Results of single-centre study of Chemosat hepatic delivery system published in...

Delcath Systems announced the publication of a retrospective analysis of patients who underwent a percutaneous hepatic perfusion procedure (PHP) with Chemosat for the treatment...
micromate

Subscription model offers a flexible option to deploy robotics in the...

This advertorial is sponsored by Interventional Systems. At the onset of the COVID-19 pandemic in early 2020, healthcare systems across the globe were forced, almost...

Transarterial radioembolization (TARE) with Yttrium-90 in paediatric primary liver tumours

Primary paediatric liver cancer is a rare disease, accounting for 1–2% of childhood cancers, or about 150 new diagnoses of paediatric liver malignancy per...
Ahmed and Ramalingam

Peritransplant vascular complications: An IR approach

In the USA, liver transplantation continues to be the best chance at long-term survival for patients suffering from the sequelae of end-stage liver disease....
curative intent

(Re)defining curative intent for HCC

Global Embolization Oncology Symposium Technologies (GEST; 19–22 May, New York, USA) provided delegates and faculty alike with the opportunity to hear about worldwide approaches...
Laura

Laura Crocetti

“I think the future success of ablation was truly unforeseeable, in 1986, when Tito Livraghi published his first paper about ethanol injection in a...

Percutaneous melphalan perfusion can induce significant responses in uveal liver metastases

Percutaneous hepatic perfusion with melphalan for the treatment of metastatic uveal melanoma (mUM) offers a hepatic response rate of 66.7% and good progression-free survival...

Clinical capabilities of Infinix-i 4D CT showcased at ECR 2018

Healthcare centres around Europe are realising a new realm of clinical efficiency with the Infinix-i 4D CT system, which seamlessly integrates interventional radiology and...

REsect study shows SIRT makes metastatic colorectal cancer patients more likely...

Metastatic colorectal cancer patients treated first-line with SIR-spheres Y-90 resin microspheres more likely to become candidates for potentially curative liver surgery, the REsect study...